1. Home
  2. GRPN vs PCRX Comparison

GRPN vs PCRX Comparison

Compare GRPN & PCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GRPN
  • PCRX
  • Stock Information
  • Founded
  • GRPN 2008
  • PCRX 2006
  • Country
  • GRPN United States
  • PCRX United States
  • Employees
  • GRPN N/A
  • PCRX N/A
  • Industry
  • GRPN Advertising
  • PCRX Biotechnology: Pharmaceutical Preparations
  • Sector
  • GRPN Consumer Discretionary
  • PCRX Health Care
  • Exchange
  • GRPN Nasdaq
  • PCRX Nasdaq
  • Market Cap
  • GRPN 1.2B
  • PCRX 1.2B
  • IPO Year
  • GRPN 2011
  • PCRX 2011
  • Fundamental
  • Price
  • GRPN $22.55
  • PCRX $23.63
  • Analyst Decision
  • GRPN Buy
  • PCRX Buy
  • Analyst Count
  • GRPN 4
  • PCRX 5
  • Target Price
  • GRPN $31.25
  • PCRX $32.40
  • AVG Volume (30 Days)
  • GRPN 1.4M
  • PCRX 532.5K
  • Earning Date
  • GRPN 11-11-2025
  • PCRX 11-05-2025
  • Dividend Yield
  • GRPN N/A
  • PCRX N/A
  • EPS Growth
  • GRPN N/A
  • PCRX N/A
  • EPS
  • GRPN N/A
  • PCRX N/A
  • Revenue
  • GRPN $487,747,000.00
  • PCRX $705,848,000.00
  • Revenue This Year
  • GRPN $4.78
  • PCRX $7.36
  • Revenue Next Year
  • GRPN $10.96
  • PCRX $10.07
  • P/E Ratio
  • GRPN N/A
  • PCRX N/A
  • Revenue Growth
  • GRPN N/A
  • PCRX 2.25
  • 52 Week Low
  • GRPN $7.75
  • PCRX $15.16
  • 52 Week High
  • GRPN $43.08
  • PCRX $27.64
  • Technical
  • Relative Strength Index (RSI)
  • GRPN 39.95
  • PCRX 32.49
  • Support Level
  • GRPN $21.60
  • PCRX $24.31
  • Resistance Level
  • GRPN $23.94
  • PCRX $26.05
  • Average True Range (ATR)
  • GRPN 1.12
  • PCRX 0.76
  • MACD
  • GRPN 0.29
  • PCRX -0.33
  • Stochastic Oscillator
  • GRPN 44.35
  • PCRX 6.34

About GRPN Groupon Inc.

Groupon Inc acts as the middleman between consumers and merchants, offering products and services at discounts via its online store. It offers consumers daily deals from local merchants. The company's operations are organized into two segments: North America and International. The company generates the majority of its revenue from North America. The company generates revenue from transactions during which the company generates commissions by selling goods or services on behalf of third-party merchants. Revenue also includes commissions the company earn when customers make purchases with retailers using digital coupons accessed through its digital properties.

About PCRX Pacira BioSciences Inc.

Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; and iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. In addition, it is developing PCRX-201 (enekinragene inzadenovec), a novel gene therapy vector platform for the treatment of osteoarthritis of the knee.

Share on Social Networks: